ViaDerma, Inc.
VDRM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6 | $7 | $15 | $13 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $6 | $7 | $15 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -0.2% | 0.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -196% | -10% | 70.3% | 38.7% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -214.1% | -22.1% | 58.2% | 26.5% |
| EPS Diluted | -0 | 0 | 0 | 0 |
| % Growth | – | -100% | – | – |
| Operating Cash Flow | -$1 | – | $0 | $0 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | -$1 | – | $0 | $0 |